Výsledky vyhledávání - "W.H. van der Laan"

LB0010 ULTRA-LOW DOSES OF RITUXIMAB OR RETREATMENT OF RHEUMATOID ARTHRITIS: A RANDOMISED CONTROLLED NON-INFERIORITY TRIAL

Autor: Bart van den Bemt, Thasia G. Woodworth, Rogier M Thurlings, Nathan den Broeder, Lise M Verhoef, Frank J. A. van den Hoogen, Alfons A den Broeder, Marc R. Kok, W. van der Weele, H.J. Bernelot Moens, W.H. van der Laan

Publikováno v: Oral Presentations.

Background Rituximab (RTX) is an effective treatment for patients with Rheumatoid Arthritis (RA). 1000mg (1 × 1000mg or 2 × 500mg) has similar 6-month efficacy as the registered dose of 2 × 1000mg. Based on several case reports and a case series e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::81c727d220bd3a714ce05c8fb581c926
https://doi.org/10.1136/annrheumdis-2019-eular.8658

Zobrazit plný text záznamu

SAT0741-HPR Cognitive-behavioural and social factors do not predict recurrent secondary health care use in patients with fibromyalgia: a longitudinal study

Autor: W.H. van der Laan, T.C. Olde Hartman, Johanna E. Vriezekolk, V.M. Vervoort, Rinie Geenen, T. van Helmond, C.H.M. van den Ende

Publikováno v: Saturday, 16 JUNE 2018.

Background Health care use in fibromyalgia (FM) is relatively high. Besides disease-related variables, cognitive-behavioural factors have been concurrently associated with health care use. It is unknown whether cognitive-behavioural and social factor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::73066645da90fd6a697d2c09b65d17f0
https://doi.org/10.1136/annrheumdis-2018-eular.2471

Zobrazit plný text záznamu

THU0752-HPR Development of the 'treatment beliefs in knee and hip osteoarthritis (TOA)' questionnaire

Autor: Henk Schers, M.W. Nijhof, C.H.M. van den Ende, Johanna E. Vriezekolk, W.H. van der Laan, E.M. Selten, Rinie Geenen, RG der Meulen-Dilling van

Publikováno v: Poster Presentations.

Background Use of non-surgical treatment modalities in osteoarthritis (OA) is suboptimal1, which might be influenced by patients9 beliefs about treatments. An instrument for measuring treatment beliefs in OA is not available yet. Objectives To develo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2e496dd81dde49feffa9490f3704b4f4
https://doi.org/10.1136/annrheumdis-2017-eular.4815

Zobrazit plný text záznamu

OP0138-HPR Do patients' treatment beliefs affect treatment choices in knee and hip osteoarthritis?

Autor: Rinie Geenen, C.H.M. van den Ende, W.H. van der Laan, Henk Schers, M.W. Nijhof, E.M. Selten, Johanna E. Vriezekolk, F.H.J. van den Hoogen, R.G. van der Meulen-Dilling

Publikováno v: Oral Presentations.

Background Patients9 beliefs about treatment modalities for knee/hip osteoarthritis (OA) might influence their treatment choices. The Theory of Planned Behavior predicts that patients9 beliefs, the norms and values of one9s social environment (subjec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::080c78e4d2e4793f15926c3263f32d0a
https://doi.org/10.1136/annrheumdis-2017-eular.4834

Zobrazit plný text záznamu

Reasons for Treatment Choices in Knee and Hip Osteoarthritis: A Qualitative Study

Autor: W.H. van der Laan, Rinie Geenen, R.G. van der Meulen Dilling, E.M. Selten, Johanna E. Vriezekolk, M.W. Nijhof, C.H.M. van den Ende, Henk Schers

Publikováno v: Arthritis Care & Research, 68, 9, pp. 1260-7
Arthritis Care & Research, 68, 1260-7

Item does not contain fulltext OBJECTIVE: Conservative treatment modalities in osteoarthritis (OA) of the hip or knee are underused, whereas the demand for surgery is rising substantially. To improve the use of conservative treatment modalities, a mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3110c7a1e7b43ae4709cda5795e0d970
https://hdl.handle.net/2066/171346

Zobrazit plný text záznamu

Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10

Autor: AL Huidekoper, René E. M. Toes, Rob G H H Nelissen, T.W.J. Huizinga, F. C. Breedveld, T C A Tolboom, W.H. van der Laan, Elsbet J. Pieterman

Publikováno v: Annals of the Rheumatic Diseases. 61:975-980

Background: Matrix metalloproteinases (MMPs) have a pivotal role in the destruction of cartilage in rheumatoid arthritis (RA), which is mediated by the fibroblast-like synoviocytes (FLS). Objective: To examine the in vitro invasiveness of synoviocyte

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a5a2fdcbcf7ba9e7e6175d83158451
https://doi.org/10.1136/ard.61.11.975

Zobrazit plný text záznamu

Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis

Autor: Ruud A. Bank, J. A. D. M. de Roos, Johan M. TeKoppele, F. C. Breedveld, Johan Hendrikus Verheijen, W.H. van der Laan, H.K. Ronday, Paul P. Tak, Christopher J. Froelich, Cornelis Erik Hack, Pancras C.W. Hogendoorn

Publikováno v: Scopus-Elsevier
Rheumatology, 1, 40, 55-61
Rheumatology (Oxford, England), 40(1), 55-61. Oxford University Press

Objective. To investigate the cartilage-degrading capacity of granzyme B and the presence of granzyme B-positive cells at sites of erosion in the rheumatoid synovium. Methods. Granzyme B was added to [3H]proline/[35S]sulphate-labelled cartilage matri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edfd5d908b166aa777151bb69eee6bf2
https://doi.org/10.1093/rheumatology/40.1.55

Zobrazit plný text záznamu

AB1087-HPR Non-Pharmacological, Non-Surgical Care in Hip and Knee Osteoarthritis: The View of Healthcare Providers

Autor: Rinie Geenen, M.W. Nijhof, E.M. Selten, R.G. van der Meulen-Dilling, Henk Schers, Johanna E. Vriezekolk, C.H.M. van den Ende, W.H. van der Laan

Publikováno v: Annals of the Rheumatic Diseases. 75:1303.2-1303

Background Non-pharmacological, non-surgical treatment modalities are underused in the management of knee and hip osteoarthritis (OA) 1 . One possible explanation of this suboptimal use could be health care providers9 lack of knowledge about non-phar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9baf19f8a392feba82a5e9ed9c68b19e
https://doi.org/10.1136/annrheumdis-2016-eular.2227

Zobrazit plný text záznamu

OP0197-HPR Psychosocial Predictors of DMARD Adherence in The First Three Months of Treatment for Early Arthritis

Autor: Y. de Man, W.H. van der Laan, Annelieke Pasma, Daan Nieboer, Cathelijne W. Y. Appels, J.M. Hazes, A. van ’t Spijker, Reinier Timman, Jan J. Busschbach

Publikováno v: Annals of the Rheumatic Diseases. 75:131.1-131

Background To induce disease remission, early arthritis patients should adhere to their disease-modifying antirheumatic drugs (DMARD) in the first months after diagnosis. 1 It remains unknown why some patients do not adhere to their therapy. Objectiv

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::96f3ad242b57af42ce64b244a78c5bb4
https://doi.org/10.1136/annrheumdis-2016-eular.1695

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání